Insights from a rare myeloproliferative neoplasm with coexisting BCR‐ABL1 fusion gene, CALR, and TET2 mutations treated with nilotinib and ruxolitinib

por Huo, Li, Xie, Jundan, Wang, Qian, Shen, Hongjie, Ding, Zixuan, Wen, Lijun, Zeng, Zhao, Xu, Yi, Ruan, Changgeng, Chen, Suning, Xue, Mengxing
Publicado 2023

The Role of Interleukin-15 Polymorphisms in Adult Acute Lymphoblastic Leukemia

por Lin, Dandan, Liu, Chunliang, Xue, Mengxing, Liu, Rengyun, Jiang, Lan, Yu, Xiao, Bao, Guangming, Deng, Fang, Yu, Mingjie, Ao, Jiafu, Zhou, Yifeng, Wu, Depei, Liu, Haiyan
Publicado 2010

Quality‐of‐life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemia

por Chen, Yilin, Xu, Na, Yang, Yunfan, Liu, Zhenfang, Xue, Mengxing, Meng, Li, He, Qun, Chen, Chunyan, Zeng, Qingshu, Zhu, Huanling, Du, Xin, Zou, Jing, He, Wenjun, Guo, Jingming, Chen, Suning, Yuan, Guolin, Wu, Hui, Hong, Mei, Cheng, Fanjun, Liu, Bingcheng, Zhang, Yanli, Li, Weiming
Publicado 2023